关注
Stavros Panagiotou
Stavros Panagiotou
Lecturer in Medical Microbiology
在 manchester.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Acute bacterial meningitis in adults
F McGill, RS Heyderman, S Panagiotou, AR Tunkel, T Solomon
The Lancet 388 (10063), 3036-3047, 2016
3202016
Therapeutic benefits of nanoparticles in stroke
S Panagiotou, S Saha
Frontiers in neuroscience 9, 182, 2015
572015
Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin
LC Jacques, S Panagiotou, M Baltazar, M Senghore, S Khandaker, R Xu, ...
Nature communications 11 (1), 1892, 2020
492020
A novel dynamic multicellular co-culture system for studying individual blood-brain barrier cell types in brain diseases and cytotoxicity testing
P Miranda-Azpiazu, S Panagiotou, G Jose, S Saha
Scientific Reports 8 (1), 8784, 2018
472018
Evolutionary trade-offs associated with loss of PmrB function in host-adapted Pseudomonas aeruginosa
L Bricio-Moreno, VH Sheridan, I Goodhead, S Armstrong, JKL Wong, ...
Nature communications 9 (1), 2635, 2018
412018
SARS-CoV-2 vaccines: fast track versus efficacy
D Alkandari, JA Herbert, MA Alkhalaf, C Yates, S Panagiotou
The Lancet Microbe 2 (3), e89-e90, 2021
302021
Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity
S Panagiotou, C Chaguza, R Yahya, T Audshasai, M Baltazar, L Ressel, ...
Scientific reports 10 (1), 17313, 2020
142020
Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection
J Clarke, M Baltazar, M Alsahag, S Panagiotou, M Pouget, WA Paxton, ...
Scientific Reports 11 (1), 19011, 2021
82021
Immune response to viruses
JA Herbert, S Panagiotou
Encyclopedia of infection and immunity, 429, 2022
72022
Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin. Nat Commun 11: 1892
LC Jacques, S Panagiotou, M Baltazar, M Senghore, S Khandaker, R Xu, ...
72020
Streptococcus pneumoniae rapidly translocate from the nasopharynx through the cribriform plate to invade the outer meninges
T Audshasai, JA Coles, S Panagiotou, S Khandaker, HE Scales, M Kjos, ...
Mbio 13 (4), e01024-22, 2022
62022
Fungal diversity in the soil Mycobiome: Implications for ONE health
A Yiallouris, ZD Pana, G Marangos, I Tzyrka, S Karanasios, I Georgiou, ...
One Health, 100720, 2024
32024
Streptococcus pneumoniae rapidly translocates from the nasopharynx through the cribriform plate to invade and inflame the dura
T Audshasai, JA Coles, S Panagiotou, S Khandaker, HE Scales, M Kjos, ...
bioRxiv, 2021.09. 28.462246, 2021
22021
The University of Manchester
S Panagiotou
United Kingdom, 0
2
Therapeutic benefits of nanoparticles in stroke.
S Saha, S Panagiotou
Frontiers in Cellular Neuroscience, 2015
12015
Novel composition
A Kadioglu, M Yang, S Panagiotou
US Patent App. 18/270,947, 2024
2024
The effect of COVID-19 on our lifestyle and microbiome: What could long term imbalanced diet and germophobia mean for our immunity?
M Almadhi, S Gharaei, JA Herbert, MA Alkhalaf, K Kahlat, C Yates, ...
Hygiene and environmental health advances 5, 100046, 2023
2023
Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity (vol 10, 17313, 2020)
S Panagiotou, C Chaguza, R Yahya, T Audshasai, M Baltazar, L Ressel, ...
SCIENTIFIC REPORTS 12 (1), 5099-, 2022
2022
Author Correction: Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity
S Panagiotou, C Chaguza, R Yahya, T Audshasai, M Baltazar, L Ressel, ...
Scientific Reports 12, 2022
2022
Method for detecting the presence of one or more bacterial toxins in a biological fluid using liposomes
A Kadioglu, D Neill, S Panagiotou
US Patent App. 16/612,198, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20